RLA-5331
Product Specifications
UNSPSC Description
RLA-5331 is an iron activator containing anti-androgen. RLA-5331 has anti-proliferative activity on metastatic castration-resistant prostate cancer (mCRPC) cell line[1].
Target Antigen
Androgen Receptor
Type
Reference compound
Related Pathways
Vitamin D Related/Nuclear Receptor
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/rla-5331.html
Solubility
10 mM in DMSO
Smiles
N#CC1=C(C=C(C=N1)N2C(C3(N(C2=S)C4=CC=C(N=C4)OC5CCN(CC5)C(O[C@@H]6CCC[C@@]7(OOC8(C9CC%10CC(CC8C%10)C9)O7)C6)=O)CCC3)=O)C(F)(F)F
Molecular Weight
808.87
References & Citations
[1]Gonciarz RL, et al. Elevated labile iron in castration-resistant prostate cancer is targetable with ferrous iron-activatable antiandrogen therapy. Eur J Med Chem. 2023 Jan 14;249:115110.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-152520/RLA-5331-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-152520/
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
